Drugs / A+C Vaccine
last change Nov 2012 re-read 2 minutes ago

A+C Vaccine

Vaccine

Developed for
meningitis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01580033 Comparator Apr → Sep 2012 influenza, meningitis Jiangsu Province Centers for Disease Control and Prevention Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as A+C Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01580033
Modality Vaccine “group A, C polysaccharide meningococcal vaccineNCT01580033
Route Intramuscular “will be administered intramuscularly on one arm, per 0.5ml dose” NCT01580033